CDH1 and gastric cancer: Furthermore, miR-217 overexpression enhances GC cell proliferation and reduces sEV CDH1 levels; hence, the imbalance of miR-217 in plasma sEVs can be used as a biomarker for GC diagnosis and classification [120].